Health Canada Approves BI’s Pradaxa for New Indications

Drug Industry Daily
A A
Canada’s health regulators have approved Boehringer Ingelheim’s blood thinner Pradaxa for new indications to treat and prevent blood clots deep in the legs and in the lungs.

To View This Article:

Login

Subscribe To Drug Industry Daily